Levin Capital Strategies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,699
| Closed | -$356K | – | 241 |
|
|
2025
Q2 | $356K | Sell |
14,699
-5,917
| -29% | -$138K | 0.03% | 140 |
|
|
2025
Q1 | $522K | Sell |
20,616
-8,217
| -28% | -$215K | 0.06% | 109 |
|
|
2024
Q4 | $765K | Buy |
28,833
+5,957
| +26% | +$162K | 0.07% | 103 |
|
|
2024
Q3 | $662K | Buy |
22,876
+14,685
| +179% | +$428K | 0.06% | 112 |
|
|
2024
Q2 | $229K | Buy |
8,191
+191
| +2% | +$5.26K | 0.02% | 183 |
|
|
2024
Q1 | $222K | Sell |
8,000
-71,848
| -90% | -$1.99M | 0.02% | 197 |
|
|
2023
Q4 | $2.3M | Sell |
79,848
-90,183
| -53% | -$2.73M | 0.25% | 62 |
|
|
2023
Q3 | $5.64M | Sell |
170,031
-13,768
| -7% | -$487K | 0.67% | 39 |
|
|
2023
Q2 | $6.74M | Sell |
183,799
-101,859
| -36% | -$3.96M | 0.77% | 35 |
|
|
2023
Q1 | $11.7M | Buy |
285,658
+2,494
| +0.9% | +$108K | 1.44% | 25 |
|
|
2022
Q4 | $14.5M | Sell |
283,164
-13,594
| -5% | -$652K | 1.95% | 15 |
|
|
2022
Q3 | $13M | Sell |
296,758
-47,863
| -14% | -$2.33M | 1.76% | 18 |
|
|
2022
Q2 | $18.1M | Sell |
344,621
-14,065
| -4% | -$717K | 2.14% | 11 |
|
|
2022
Q1 | $18.6M | Sell |
358,686
-16,254
| -4% | -$843K | 1.79% | 17 |
|
|
2021
Q4 | $22.1M | Sell |
374,940
-10,710
| -3% | -$531K | 2.07% | 14 |
|
|
2021
Q3 | $16.6M | Buy |
385,650
+3,579
| +0.9% | +$159K | 1.66% | 20 |
|
|
2021
Q2 | $15M | Buy |
382,071
+175,459
| +85% | +$6.82M | 1.53% | 21 |
|
|
2021
Q1 | $7.49M | Buy |
206,612
+10,699
| +5% | +$380K | 0.8% | 32 |
|
|
2020
Q4 | $7.21M | Sell |
195,913
-19,719
| -9% | -$723K | 0.81% | 32 |
|
|
2020
Q3 | $7.51M | Buy |
215,632
+14,419
| +7% | +$506K | 0.98% | 30 |
|
|
2020
Q2 | $6.24M | Sell |
201,213
-187,261
| -48% | -$6.36M | 0.86% | 35 |
|
|
2020
Q1 | $12M | Sell |
388,474
-312,709
| -45% | -$10.7M | 1.94% | 17 |
|
|
2019
Q4 | $26.1M | Sell |
701,183
-36,661
| -5% | -$1.31M | 2.6% | 12 |
|
|
2019
Q3 | $25.2M | Sell |
737,844
-321,312
| -30% | -$11.7M | 2.78% | 10 |
|
|
2019
Q2 | $43.5M | Buy |
1,059,156
+136,503
| +15% | +$5.42M | 4.3% | 3 |
|
|
2019
Q1 | $37.2M | Sell |
922,653
-3,687,354
| -80% | -$148M | 4.17% | 6 |
|
|
2018
Q4 | $191M | Sell |
4,610,007
-2,124,476
| -32% | -$88.2M | 4.2% | 5 |
|
|
2018
Q3 | $282M | Sell |
6,734,483
-187,561
| -3% | -$7.22M | 4.84% | 2 |
|
|
2018
Q2 | $238M | Sell |
6,922,044
-551,922
| -7% | -$18.9M | 4.11% | 5 |
|
|
2018
Q1 | $252M | Sell |
7,473,966
-2,374,278
| -24% | -$81.6M | 4.58% | 2 |
|
|
2017
Q4 | $338M | Sell |
9,848,244
-1,003,927
| -9% | -$34.2M | 5.72% | 1 |
|
|
2017
Q3 | $368M | Buy |
10,852,171
+693,867
| +7% | +$22.3M | 6.23% | 1 |
|
|
2017
Q2 | $324M | Buy |
10,158,304
+1,224,540
| +14% | +$38.6M | 5.65% | 2 |
|
|
2017
Q1 | $290M | Buy |
8,933,764
+172,304
| +2% | +$5.43M | 5.17% | 2 |
|
|
2016
Q4 | $270M | Buy |
8,761,460
+500,021
| +6% | +$15.3M | 4.64% | 2 |
|
|
2016
Q3 | $265K | Buy |
8,261,439
+1,184,937
| +17% | +$39.6M | 3.9% | 3 |
|
|
2016
Q2 | $236M | Sell |
7,076,502
-4,456,802
| -39% | -$142M | 4.26% | 5 |
|
|
2016
Q1 | $324M | Sell |
11,533,304
-245,817
| -2% | -$7.02M | 5.87% | 1 |
|
|
2015
Q4 | $361M | Buy |
11,779,121
+4,447,343
| +61% | +$140M | 6.34% | 1 |
|
|
2015
Q3 | $218M | Buy |
7,331,778
+573,727
| +8% | +$18.4M | 3.73% | 3 |
|
|
2015
Q2 | $215M | Sell |
6,758,051
-1,660,879
| -20% | -$54.1M | 3.18% | 5 |
|
|
2015
Q1 | $278M | Sell |
8,418,930
-2,673,874
| -24% | -$85M | 4.16% | 2 |
|
|
2014
Q4 | $328M | Buy |
11,092,804
+474,149
| +4% | +$13.6M | 4.95% | 1 |
|
|
2014
Q3 | $298M | Buy |
10,618,655
+499,716
| +5% | +$14M | 4.53% | 1 |
|
|
2014
Q2 | $285M | Buy |
10,118,939
+2,182,146
| +27% | +$62.2M | 4.39% | 1 |
|
|
2014
Q1 | $242M | Sell |
7,936,793
-660,546
| -8% | -$19.7M | 4.05% | 3 |
|
|
2013
Q4 | $250M | Sell |
8,597,339
-2,800,526
| -25% | -$81.5M | 4.02% | 4 |
|
|
2013
Q3 | $311M | Buy |
11,397,865
+1,123,793
| +11% | +$30.6M | 5.3% | 1 |
|
|
2013
Q2 | $273M | Buy |
+10,274,072
| New | +$284M | 4.91% | 2 |
|
Other funds holding PFE
Levin Capital Strategies's PFE Position: Q3 2025 in Review
Levin Capital Strategies sold out of Pfizer (PFE) in Q3 2025, closing a stake of 14,699 shares — an estimated $356K sold.
Levin Capital Strategies first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $368M in Q3 2017. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Levin Capital Strategies reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Levin Capital Strategies sold 14,699 Pfizer shares in Q3 2025, an estimated $356K.
- Levin Capital Strategies first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
- Levin Capital Strategies's Pfizer position peaked at $368M in Q3 2017.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Levin Capital Strategies's 13F filing for Q3 2025, filed 7 Nov 2025.